Tumor hypoxia is considered as one of the major factors that limit the efficiency of photodynamic therapy (PDT), in which oxygen (O 2 ) is needed to generate singlet oxygen ( 1 O 2 ) for cell destruction. Inspired by the excellent O 2 carrying ability of perfluorocarbon molecules in artificial blood, we prepared a series of polymer micelles with a perfluorocarbon core to carry both photo-sensitizer and O 2 to the tumor site, aiming to improve PDT efficiency. We found that the accelerated generation of 1 O 2 correlated with the increased perfluorocarbon amount in solution. In vitro cell study further showed that the new perfluorocarbon formulation not only improved the production of 1 O 2 , leading to enhanced photodynamic therapy efficiency...
The efficacy of photodynamic therapy (PDT) is often limited by the poor bio-distributive properties ...
Tumor therapy is facing great challenges in improving drug efficiency while reducing side effects. H...
Objective A hydrophobic photosensitizer, 2‐[1‐hexyloxyethyl]‐2‐devinyl pyropheophorbide‐a (HPPH), w...
Nanomaterials have been used in the treatment of cancer to increase the solubility of insoluble payl...
With an estimated failure rate of about 90%, immunotherapies that are intended for the treatment of ...
<p>Photodynamic therapy (PDT) requires photosensitizer, light, and oxygen to induce cell death. The ...
The efficacy of photodynamic therapy (PDT) in the solid tumor is hampered by many challenges, includ...
Photodynamic therapy (PDT) has been used in the treatment of cancers and other benign diseases for s...
Integration of photosensitizers (PSs) within nanoscale delivery systems offers great potential for o...
Perfluorocarbon (PFC) are biocompatible compounds, chemically and biologically inert, and lacks toxi...
First and second generation photosensitizers used in photodynamic therapy (PDT) have shown promising...
This study relates to nanoparticle (NP) platforms that attach to tumor cells externally and only del...
Over the past five years, oxygen-based nanocarriers (NCs) to boost anti-tumor therapy attracted trem...
This article presents the development and characterization of nanoparticles loaded with methylene bl...
A light-activated hypoxia-responsive conjugated polymer-based nanocarrier is developed for efficient...
The efficacy of photodynamic therapy (PDT) is often limited by the poor bio-distributive properties ...
Tumor therapy is facing great challenges in improving drug efficiency while reducing side effects. H...
Objective A hydrophobic photosensitizer, 2‐[1‐hexyloxyethyl]‐2‐devinyl pyropheophorbide‐a (HPPH), w...
Nanomaterials have been used in the treatment of cancer to increase the solubility of insoluble payl...
With an estimated failure rate of about 90%, immunotherapies that are intended for the treatment of ...
<p>Photodynamic therapy (PDT) requires photosensitizer, light, and oxygen to induce cell death. The ...
The efficacy of photodynamic therapy (PDT) in the solid tumor is hampered by many challenges, includ...
Photodynamic therapy (PDT) has been used in the treatment of cancers and other benign diseases for s...
Integration of photosensitizers (PSs) within nanoscale delivery systems offers great potential for o...
Perfluorocarbon (PFC) are biocompatible compounds, chemically and biologically inert, and lacks toxi...
First and second generation photosensitizers used in photodynamic therapy (PDT) have shown promising...
This study relates to nanoparticle (NP) platforms that attach to tumor cells externally and only del...
Over the past five years, oxygen-based nanocarriers (NCs) to boost anti-tumor therapy attracted trem...
This article presents the development and characterization of nanoparticles loaded with methylene bl...
A light-activated hypoxia-responsive conjugated polymer-based nanocarrier is developed for efficient...
The efficacy of photodynamic therapy (PDT) is often limited by the poor bio-distributive properties ...
Tumor therapy is facing great challenges in improving drug efficiency while reducing side effects. H...
Objective A hydrophobic photosensitizer, 2‐[1‐hexyloxyethyl]‐2‐devinyl pyropheophorbide‐a (HPPH), w...